Endologix Announces FDA Approval of AFX Endovascular AAA System

Endologix, Inc. ELGX announced today that it has received U.S. Food and Drug Administration approval for its next generation product, the AFX™ Endovascular AAA System, for the treatment of abdominal aortic aneurysms . Endologix is introducing AFX at the Annual Meeting of the Society for Vascular Surgery, which is taking place June 16-18, 2011 in Chicago, IL.